USPTO 2015–2025 USPTO PatentsView US Corporation

Dupont Industrial Biosciences USA, Llc

USPTO PatentsView assignee record - 36 granted patents across 37 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08B (POLYSACCHARIDES; DERIVATIVES THEREOF).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

17.8

Avg claims per patent

+1000%

5-year filing velocity

The verdict

Dupont holds 36 US patents across 37 technology areas, rank #8,785 of 50,000 tracked assignees.

#8,785
of 50,000 US assignees by volume: Top 24%
by Innovation Score (44.9/100): 17.8
avg claims per patent: +1000%
filing velocity, last 5 yrs

Portfolio overview

Dupont Industrial Biosciences USA, Llc has been granted 36 US utility patents between 2019 and 2025, placing Dupont Industrial Biosciences USA, Llc at rank #8,785 across all assignees tracked by PlainPatent. This portfolio spans 37 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.8 claims per patent with primary concentration in C08B (POLYSACCHARIDES; DERIVATIVES THEREOF). As a US Corporation, Dupont Industrial Biosciences USA, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Dupont sits between Development Center For Biotechnology (36 patents, rank #8,781) and Echelon Corporation (36 patents, rank #8,789) - the closest US assignees by grant volume. The composite Innovation Score of 44.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 33 grants, compared with 3 in the 2015–2019 window, a +1000% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Dupont Industrial Biosciences USA, Llc's 17.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 37 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Dupont Industrial Biosciences USA, Llc against peers pursuing similar technology classes.

Development Cente…

36
Diehl AKO Stiftun…

36
Drfirst com

36
Draeger Medical S…

36
Dynacraft BSC

36
E2interactive

36
Encell Technology

36
Echelon

36
Dupont Industrial… ◀

36

What this shows Dupont holds 36 patents at rank #8,785, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dupont

By rank, the assignees closest to #8,785 in granted patent volume.

Leaders in C08B (Polysaccharides)

Other assignees with the most granted patents in Dupont's primary technology class.

Dupont's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Dupont Industrial Biosciences USA, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	8.3%
2020	25	69.4%
2021	6	16.7%
2022	1	2.8%
2025	1	2.8%

Which technologies does Dupont Industrial Biosciences USA, Llc patent most?

C08B - POLYSACCHARIDES; DERIVATIVES THEREOF 24

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 21

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 16

C12Y - ENZYMES 10

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 10

C11D - DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL 8

C07D - HETEROCYCLIC COMPOUNDS 7

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 7

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 6

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 4

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 4

D21H - PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR 3

D04H - MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL ; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION 3

D01F - CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS 3

D01D - MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS 3

Top 15 of 37 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#8,785

Across all tracked assignees

Innovation Score

44.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Dupont Industrial Biosciences USA, Llc hold?

Dupont Industrial Biosciences USA, Llc holds 36 US granted patents filed between 2019 and 2025, spanning 37 technology areas.

What is Dupont Industrial Biosciences USA, Llc's Innovation Score?

Dupont Industrial Biosciences USA, Llc has an Innovation Score of 44.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dupont Industrial Biosciences USA, Llc focus on?

Dupont Industrial Biosciences USA, Llc's top technology area is C08B (POLYSACCHARIDES; DERIVATIVES THEREOF) with 24 patents. The company has filed patents in 37 CPC subclasses total.

Is Dupont Industrial Biosciences USA, Llc's patent filing rate increasing or decreasing?

Dupont Industrial Biosciences USA, Llc's recent filing velocity is +1000% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Dupont Industrial Biosciences USA, Llc's patents?

Dupont Industrial Biosciences USA, Llc's patents average 17.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Dupont Industrial Biosciences USA, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Dupont's 36 grants land it in the top 24% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Dupont ranks #8,785 of 50,000. Top 50 holders
Most of this portfolio concentrates in C08B - see who else leads that technology area. C08B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.